DR. CHRISTOPHER NG M.D. NPI 1124002845

NPI Details

DR. Christopher Ng, M.D. is a specialist in Los Angeles, CA with 29 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Christopher Ng, M.D. NPI is 1124002845. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

8635 W 3RD ST
SUITE 1 WEST
LOS ANGELES, CA
ZIP 90048-101
Phone: (310) 854-9898
Fax: (310) 854-0267

The NPI 1124002845 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Complete ultrasound scan of pelvis (HCPCS:76856)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Testosterone (hormone) level, total (HCPCS:84403)
• Bacterial colony count, urine (HCPCS:87086)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Limited ultrasound scan of pelvis (HCPCS:76857)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) (HCPCS:87184)
• Kidney function blood test panel (HCPCS:80069)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Uric acid level, blood (HCPCS:84550)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
• Liver function blood test panel (HCPCS:80076)
• Vitamin d-3 level (HCPCS:82306)
• Insertion of lower leg neurostimulator electrode (HCPCS:64566)
• Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming (HCPCS:95971)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Identification of organisms by immunologic analysis, other than immunofluorescence method (HCPCS:87147)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, tobramycin sulfate, up to 80 mg (HCPCS:J3260)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Complicated insertion of bladder tube (HCPCS:51703)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Wet mounts, including preparations of vaginal, cervical or skin specimens (HCPCS:Q0111)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Biopsy of prostate gland (HCPCS:55700)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Hemoglobin a1c level (HCPCS:83036)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Complete laser vaporization of prostate including control of bleeding using an endoscope (HCPCS:52648)
• Incision of prostate (HCPCS:52450)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Complete ultrasound of penis artery and vein blood flow (HCPCS:93980)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Ultrasound scan of scrotum (HCPCS:76870)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 12/6/2005 and was last updated on 7/9/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.